Cargando…
60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335500/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.062 |
| _version_ | 1783733120445448192 |
|---|---|
| author | Pepe, P.E. Antevy, P.M. Marty, A.M. Jui, J. Cabral, M. Rosenberg, L. Scheppke, K.A. |
| author_facet | Pepe, P.E. Antevy, P.M. Marty, A.M. Jui, J. Cabral, M. Rosenberg, L. Scheppke, K.A. |
| author_sort | Pepe, P.E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8335500 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83355002021-08-04 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination Pepe, P.E. Antevy, P.M. Marty, A.M. Jui, J. Cabral, M. Rosenberg, L. Scheppke, K.A. Ann Emerg Med Abstract Elsevier, Inc. 2021-08 2021-08-04 /pmc/articles/PMC8335500/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.062 Text en © 2021 Elsevier, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Abstract Pepe, P.E. Antevy, P.M. Marty, A.M. Jui, J. Cabral, M. Rosenberg, L. Scheppke, K.A. 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination |
| title | 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination |
| title_full | 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination |
| title_fullStr | 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination |
| title_full_unstemmed | 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination |
| title_short | 60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination |
| title_sort | 60 presence and degree of neutralizing antibody production following pfizer-biontech vaccination |
| topic | Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335500/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.062 |
| work_keys_str_mv | AT pepepe 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination AT antevypm 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination AT martyam 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination AT juij 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination AT cabralm 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination AT rosenbergl 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination AT scheppkeka 60presenceanddegreeofneutralizingantibodyproductionfollowingpfizerbiontechvaccination |